(Total Views: 528)
Posted On: 01/23/2022 7:15:56 PM
Post# of 153999
Re: craigakess #115802
Craig,
I’ll respond assuming that your inquiry is genuine. Cases in Brazil in October and November averaged 70K per week, dropping to 22k the penultimate week of December.
Cases now averaging 149k per day.
From the nadir of the Delta wave, cases have increased nearly 50 fold (47.4 times)
Very difficult to enroll a clinical trial.
As ICU occupancy in São Paulo state (largest concentration of Leronlimab trials sites) has more than tripled in the last three weeks, with hospitalizations lagging infections.
That is what has changed.
I’ll respond assuming that your inquiry is genuine. Cases in Brazil in October and November averaged 70K per week, dropping to 22k the penultimate week of December.
Cases now averaging 149k per day.
From the nadir of the Delta wave, cases have increased nearly 50 fold (47.4 times)
Very difficult to enroll a clinical trial.
As ICU occupancy in São Paulo state (largest concentration of Leronlimab trials sites) has more than tripled in the last three weeks, with hospitalizations lagging infections.
That is what has changed.
(9)
(0)
